Trade

with

Omnicare Inc
(NYSE: OCR)
AdChoices
64.23
+1.14
+1.81%
After Hours :
-
-
-

Open

63.52

Previous Close

63.09

Volume (Avg)

693.38k (837.54k)

Day's Range

63.24-64.46

52Wk Range

52.26-67.49

Market Cap.

6.17B

Dividend Rate (Yield )

0.80 (1.27%)

Beta

1.28

Shares Outstanding

97.85M

P/E Ratio (EPS)

59.88 (-)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Care
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 6.01B

    • Net Income

    • -43.43M

    • Market Cap.

    • 6.17B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1.03

    • PEG (Price/Earnings Growth) Ratio

    • 1.56

    • Beta

    • 1.28

    • Forward P/E

    • 15.22

    • Price/Sales

    • 1.10

    • Price/Book Value

    • 2.37

    • Price/Cash flow

    • 11.40

      • EBITDA

      • 430.81M

      • Return on Capital %

      • -0.96

      • Return on Equity %

      • -2.11

      • Return on Assets %

      • -0.96

      • Book Value/Share

      • 26.57

      • Shares Outstanding

      • 97.85M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.20 (9/18/2014)

      • Dividend Declaration Date

      • 9/12/2014

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 68.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 3.38

        • Cashflow Estimate

        • 5.37

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 7.10

          • 10.91

          • Net Income

            YTD/YTD (last year)

          • -56.40

          • 13.51

          • Net Income

            Q/Q (last year)

          • 29.50

          • 9.25

          • Sales (Revenue)

            5-Year Annual Average

          • -0.96

          • 22.28

          • Net Income

            5-Year Annual Average

          • -11.50

          • 7.43

          • Dividends

            5-Year Annual Average

          • 47.11

          • 7.69

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 22.85

            • 20.03

            • Pre-Tax Margin

            • 3.56

            • 6.27

            • Net Profit Margin

            • -1.03

            • 3.77

            • Average Gross Margin

              5-Year Annual Average

            • 23.30

            • 20.79

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 3.30

            • 6.01

            • Average Net Profit Margin

              5-Year Annual Average

            • 1.10

            • 210.16B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.66

              • 0.69

              • Current Ratio

              • 1.70

              • 1.48

              • Quick Ratio

              • 0.92

              • 0.75

              • Interest Coverage

              • -

              • 11.79

              • Leverage Ratio

              • 2.50

              • 2.42

              • Book Value/Share

              • 26.57

              • 17.00

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 59.88

                • 23.92

                • P/E Ratio 5-Year High

                • 64.16

                • 103.00

                • P/E Ratio 5-Year Low

                • 18.20

                • 15.89

                • Price/Sales Ratio

                • 1.10

                • 0.84

                • Price/Book Value

                • 2.37

                • 3.25

                • Price/Cash Flow Ratio

                • 11.40

                • 11.21

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 70.35

                    • Dividend Date

                    • 9/12/2014

                    • Ex-Dividend Date

                    • 9/18/2014

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -2.11

                        (1.90)

                      • 12.59

                        (10.63)

                      • Return on Assets %

                        (5-Year Average)

                      • -0.96

                        (0.90)

                      • 6.43

                        (5.79)

                      • Return on Capital %

                        (5-Year Average)

                      • -1.24

                        (2.40)

                      • 8.91

                        (7.75)

                      • Income/Employee

                      • -

                      • 8.31k

                      • Inventory Turnover

                      • 11.87

                      • 9.85

                      • Asset Turnover

                      • 0.93

                      • 1.70

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      297.85M
                      Operating Margin
                      4.95
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      11.40
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      47.30%

                      Mutual Fund Ownership

                      60.00%

                      Float

                      99.27%

                      5% / Insider Ownership

                      4.38%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Oakmark Equity and Income Fund

                      •  

                        4,065,250

                      • -13.88

                      • 4.15

                      • Harris Assoc. Equity & Income Strategy

                      •  

                        4,065,250

                      • -13.88

                      • 4.15

                      • Vanguard Selected Value Fund

                      •  

                        3,448,200

                      • 0.00

                      • 3.52

                      • JHancock Disciplined Value Mid Cap Fund

                      •  

                        2,267,075

                      • 1.65

                      • 2.32

                      • Janus Contrarian Fund

                      •  

                        1,749,258

                      • 0.00

                      • 1.79

                      • Vanguard Small Cap Index

                      •  

                        1,699,677

                      • -1.53

                      • 1.74

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,608,060

                      • 0.38

                      • 1.64

                      • JHancock Disciplined Value Fund

                      •  

                        1,550,565

                      • 4.98

                      • 1.58

                      • RidgeWorth Mid-Cap Value Equity Fund

                      •  

                        1,465,000

                      • 4.64

                      • 1.50

                      • iShares Core S&P Mid-Cap (AU)

                      •  

                        1,341,201

                      • -4.14

                      • 1.38

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Robeco Investment Management, Inc.

                      •  

                        7,284,778

                      • +11.10%

                      • 7.44

                      • Vanguard Group, Inc.

                      •  

                        6,719,909

                      • +0.79%

                      • 6.87

                      • Harris Associates L.P.

                      •  

                        5,471,790

                      • -11.85%

                      • 5.59

                      • Iridian Asset Management LLC

                      •  

                        5,153,368

                      • -2.22%

                      • 5.27

                      • Barrow, Hanley, Mewhinney & Strauss LLC.

                      •  

                        4,996,755

                      • +4.09%

                      • 5.11

                      • State Street Corp

                      •  

                        3,707,283

                      • -1.84%

                      • 3.79

                      • ARONSON+JOHNSON+ORTIZ

                      •  

                        3,640,480

                      • +56.45%

                      • 3.72

                      • Janus Capital Management LLC

                      •  

                        3,615,841

                      • -1.09%

                      • 3.69

                      • BlackRock Fund Advisors

                      •  

                        3,109,317

                      • -3.99%

                      • 3.18

                      • Dimensional Fund Advisors, Inc.

                      •  

                        2,578,994

                      • -0.48%

                      • 2.64

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Care

                      Type

                      Distressed

                      Style

                      Mid Core

                      Omnicare Inc was formed in 1981. It is a healthcare services company that provides complex pharmaceutical care. It operates in two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG). Through LTC, the Compan...morey provides pharmaceuticals and related pharmacy and ancillary services to long-term care facilities as well as chronic care facilities and other settings. SCG provides commercialization services for the biopharmaceutical industry in addition to end-of-life pharmaceutical care management for hospice care agencies. With respect to its clinical services, the Company provides pharmacy consulting, including monthly patient drug therapy evaluations, assist in compliance with state and federal regulations and provide proprietary clinical and health management programs. LTC also...more provides a suite of technology solutions based on its Omniview web-based platform that is intended to improve the efficiency of its customers' operations through such tools as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage, among others. LTC also provides a number of other products and services, including intravenous medications and nutrition products (infusion therapy products and services), respiratory therapy services, medical supplies and equipment (including billing the Medicare Part B program for eligible patients) and clinical care planning. The Company also provides pharmaceutical case management services for retirees, employees and dependents who have drug benefits under corporate-sponsored healthcare programs. SCG touches a broad spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its services are largely centered on the specialty pharmaceutical market. These services are based on five platforms: brand support services, third party logistics, patient assistance programs, specialty pharmacy and disease management for end-of-life care. Its brand support services, third party logistics and patient assistance programs are integrated, fee-for-service platforms which focus on helping the drug manufacturer to market, to distribute and obtain reimbursement for their products. In its specialty pharmacy platform, the Company provides dispensing of specialized pharmaceuticals that are high cost, have complex reimbursement and supply chain challenges, have limited patient populations and are not available through normal retail channels. These specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology and growth hormones. LTC's customers consist of skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers. The Company’s largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company’s pharmacies and the long-term care institutions it serves are subject to extensive federal, state and local regulation.lessless

                      Key People

                      Nitin Sahney

                      CEO/President/Director

                      James D. Shelton

                      Chairman of the Board/Director

                      Mr. Robert Kraft

                      CFO/Chief Accounting Officer/Senior VP

                      Barry P. Schochet

                      Director

                      Amy Wallman

                      Director

                      • Omnicare Inc

                      • 900 Omicare Center

                      • Cincinnati, OH 45202

                      • USA.Map

                      • Phone: +1 513 719-2600

                      • Fax: -

                      • omnicare.com

                      Incorporated

                      1981

                      Employees

                      13,900

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: